Collaboration Forms for Development of Targeted Immunotherapies to Treat Cancer (European Pharmaceutical Manufacturer Magazine)
UF startup and UF Innovate | Sid Martin Biotech alumni company Morphogenesis — a Florida-based immunotherapy company — and the Cell and Gene Therapy Group at Karolinska Institutet (KI) in Sweden have announced a collaboration for the development of targeted immunotherapies to treat cancer. The two-and-a-half-year collaboration will combine Morphogenesis’ gene therapy with the exosome-mediated […]
Venturing Out? Here’s How to Find Funding (Business in Greater Gainesville)
In this article in Business in Greater Gainesville, Mark Long suggests a number of ways to brand a new venture — and “approach a venture capitalist” doesn’t top the list. If you’re looking to finance a startup or new business, check out Mark’s list of sources for funding in the September issue of the magazine. […]
Morphogenesis Focused on Cancer Treatment Launches First Human Clinical Study (Tampa Bay Business Journal)
UF startup Morphogenesis Inc. is launching its first human clinical study for treatment for skin cancer. It’s an important benchmark for the Tampa company, a UF Innovate | Sid Martin Biotech alumnus, which raised $16 million earlier this year in a Series A investment round led by entrepreneur and philanthropist Dr. Kiran Patel. The Phase […]
Philips Expands Its Monitoring & Analytics Business with the Acquisition of UF Startup Xhale Assurance Inc. (Philips.com)
Royal Philips, a global leader in health technology, announced that it has acquired UF startup Xhale Assurance Inc, a US-based scale-up company developing and commercializing next-generation sensor technologies. Xhale Assurance’s unique, disposable pulse oximetry sensor is placed on the wing (ala) of the nose, and can reliably measure and transmit a patient’s heart rate and […]
USDA Awards Grant to Biotech Startup Pheronym (WCJB)
The federal government is supporting the groundbreaking work of another biotech startup in Alachua County. The USDA has awarded a $500,000 grant to Pheronym, which works out of UF Innovate | Sid Martin Biotech. Pheronym started in the Hatchery at UF Innovate | The Hub before moving to its sister business incubator. Pheronym is developing […]
Ology Bioservices Wins $8.4 Million Defense Department Award to Produce Anti-Ebola Medical Countermeasure (BioFlorida)
UF startup and UF Innovate | Sid Martin Biotech alumn Ology Bioservices, Inc., a biologics contract development and manufacturing organization (CDMO), announced that it was awarded an Other Transaction Agreement (OTA) to support the Joint Project Manager Medical Countermeasure Systems (JPM-MCS), a component of the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear […]
AxoGen Invests $5M in Dayton, Ohio, Site for Expanded Operations (Dayton Daily News)
UF startup and UF Innovate | Sid Martin Biotech alum AxoGen, a medical devices manufacturer, has purchased a Vandalia building and land for $5 million for nerve graft work. AxoGen Inc., its principal executive office located in Alachua, bought the 2,400-square-foot building at 913 Industrial Park for $5 million, Montgomery County property records show. Just […]
Oragenics, Inc. Resumes Phase 2 Clinical Trial of AG013 in Oral Mucositis Following Positive Routine Safety Review (Business Wire)
UF Innovate | Sid Martin alumni startup Oragenics, Inc., a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis (OM), announced it has resumed its Phase 2 clinical trial of AG013, a live biotherapeutic product for the potential treatment of OM following a positive review by an independent […]
Sarepta Carries Lacerta Through $30M Round (Global University Venturing)
UF Innovate | Sid Martin Biotech resident client Lacerta Therapeutics, a US-based gene therapy startup of University of Florida, received $30m in funding from biopharmaceutical firm Sarepta Therapeutics. Founded in 2017, Lacerta Therapeutics is developing gene therapy programs for rare, inherited metabolic conditions, known as lysosomal storage disorders, such as Pompe disease and the fatal […]
UF Innovate | Sid Martin Biotech Resident Company Lacerta Therapeutics, Inc. Closes On $30 million Investment Round (Business Wire)
UF Innovate | Sid Martin Biotech, the leading biotechnology incubator at the University of Florida, announces resident company Lacerta Therapeutics, Inc., has closed on a $30 million investment round. UF startup Lacerta is a clinical-stage gene therapy company using a constellation of proprietary adeno-associated virus (AAV) vector technologies to develop treatments for central nervous system […]